Skip to main content
Premium Trial:

Request an Annual Quote

Greg Lennon Joins Gene Logic as V-P of Genomics


COLUMBIA, Md.--Gene Logic, a drug discovery company here that relies on proprietary bioinformatics software, has named Greg Lennon as vice-president of genomics. Lennon was formerly a senior scientist at the Lawrence Livermore National Laboratory and manager of the functional genomics research portfolio for the Joint Genome Institute of the US Department of Energy (DOE).

He previously collaborated with Keith Elliston--now Gene Logic's senior vice-president and chief scientific officer--to implement the Merck Gene Index project, which coordinated the efforts of Merck, the Livermore Lab, Washington University, the University of Pennsylvania, and the National Center for Biotechnology Information in a major gene sequencing effort. In addition to his new position, Lennon will continue to direct the DOE-funded Integrated Molecular Analysis of Genome Expression Consortium, which supports such initiatives as the Cancer Genome Anatomy Project and the HHMI-Washington University Mouse EST project.

Filed under

The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.